2024-01-09 06:23:23
Title: Researchers Push for Approval of MDMA as Treatment for PTSD
Date: January 9, 2024
Author: Nico Reiter
In a groundbreaking study, researchers at the University of California have found promising results for the use of MDMA, commonly known as a party drug, as a treatment for post-traumatic stress disorder (PTSD). The study, led by neurologist Jennifer Mitchell, showed that MDMA can have a significant impact on PTSD patients when used in conjunction with psychotherapy.
Over 18 weeks, participants in the study received MDMA three times in addition to regular psychotherapy. The results were striking, with 71% of patients in the medication group no longer meeting diagnostic criteria for PTSD after treatment, compared to only 48% in the control group who received placebo pills. The study also found no physical dependence on MDMA, and while psychological symptoms and flashbacks occurred, they were not significantly different from the placebo group.
MDMA, which has both empathogenic and entactogenic effects, can increase social interaction and awareness of one’s own feelings. This can be crucial in reducing the fear of memories and inhibitions about discussing them in therapy for PTSD patients.
The positive results from this study are building momentum for the approval of MDMA as a treatment for PTSD. Already in Australia, the drug has been approved for trauma therapy, and the research team hopes to see similar approval in the United States. However, the road to approval in Germany and Europe may take several years.
While the use of MDMA in trauma therapy raises questions about its long-term effects and potential for abuse, the promising results from this study are a step forward in providing effective treatment for PTSD patients. With further research and potential approvals on the horizon, the use of MDMA could revolutionize the way PTSD is treated in the future.]
#MDMA #helps #people #posttraumatic #stress #disorder